Combino Pharm presents a new business opportunity with the product Zoledronic Acid (Ready to Use RTU):
- Product description: Zoledronic Acid Ready to Use
- Reference product: Zometa® (Novartis)
- Therapeutical indication: treatment of multiple myeloma and bone metastases from solid tumours, in conjunction with standard antineoplasic therapy
- Presentation: plastic bags 4mg/100ml
- Highlights: ready to use pharmaceutical form, dossier available for submission
- Patent status: European Product Patent: May 2013 (PED)
- Regulatory details: the product is produced in an EU Manufacturing site, CPP available from PT and ES (expected 3Q 2012)
- Regulatory strategy: dossier completed with an on-going DCP in PT and ES